Business Context and Reporting Period
This Form 8-K reports on the Special Meeting of Stockholders held by Better Choice Company Inc. on March 21, 2025. The filing details the voting outcomes for three primary proposals: a corporate name change, an acquisition arrangement, and an amendment to the equity incentive plan. The company is incorporated in Delaware and trades on the NYSE American under the symbol BTTR.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
Of the 1,980,099 shares outstanding, 1,419,942 shares (71.71%) were present or represented by proxy. The voting results were as follows:
- Name Change Proposal: Approved. Stockholders voted to change the legal name to "SRX Health Solutions, Inc." and the ticker symbol to "SRXH".
- For: 1,359,116
- Against: 54,152
- Abstain: 6,674
- Arrangement Proposal: Approved. Stockholders voted to issue up to 30,000,000 shares to acquire SRx Health Solutions, Inc.
- For: 1,088,501
- Against: 27,424
- Abstain: 638
- Broker Non-Vote: 303,379
- Plan Proposal: Approved. Stockholders voted to increase the number of securities available under the 2019 Incentive Award Plan.
- For: 1,026,385
- Against: 51,321
- Abstain: 38,857
- Broker Non-Vote: 303,379
- Adjournment Proposal: Approved. Stockholders authorized the Board to adjourn the meeting if necessary to solicit additional proxies.
- For: 1,073,679
- Against: 29,675
- Abstain: 13,209
- Broker Non-Vote: 303,379
Guidance, Outlook, and Risks
The filing does not contain management commentary on future financial guidance, outlook, or specific risk factors. The primary operational change indicated is the pending acquisition of SRx Health Solutions, Inc., contingent on the approved share issuance.
Investor Verification Checklist
- Confirm the effective date of the ticker symbol change from BTTR to SRXH.
- Review the definitive proxy statement filed on January 28, 2025, for detailed terms of the SRx acquisition arrangement.
- Verify the dilution impact of the issuance of up to 30,000,000 new shares.
- Check subsequent filings for the updated capitalization table post-transaction.